Skip to main content
All lobbying filings

Artemis Policy Group LLC

Artemis Policy Group LLC filed a Q1 report for National Bleeding Disorder Foundation (FKA National Hemophilia Foundation) on April 20, 2026, reporting $50,000 in lobbying income.

Lobbying for National Bleeding Disorder Foundation (FKA National Hemophilia Foundation) · Nonprofit supporting patients with inheritable bleeding disorders.

As filed: ARTEMIS POLICY GROUP LLC for NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION).

All filings by Artemis Policy Group LLC · Everything National Bleeding Disorder Foundation (FKA National Hemophilia Foundation) has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
New York

Official filing document

 Lobbyists on this filing 2
  • JOHANNA GRAY
    Previously held: Intern, Senator Barack Obama
  • LESLIE BRADY
    Previously held: Health Policy Advisor/Legislative Assistant, Rep. Brian Higgins

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 9

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 6
Medicare/Medicaid

Implementation of H.R. 1, One Big Beautiful Bill Act Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Preserving and expanding access to Medicaid Issues related to 1115 of the Social Security Act; policies related to work requirements in Medicaid Comments on RE: CMS-5545-P: Global Benchmark for Efficient Drug Pricing (GLOBE) Model Comments on CMS-5546-P: Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model

Health Issues

Blood and plasma safety and awareness Bleeding disorders awareness

Insurance

Implementation of H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834 Comments on Proposed Rule: Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (CMS-9883-P)

Budget/Appropriations

Funding for federal hemophilia programs in FY26 and FY27 House and Senate Labor-HHS Appropriations bills NIH FY26 and FY27 appropriations

Pharmacy

Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program

Medical/Disease Research/Clinical Labs

Hemophilia research, prevention, surveillance and service programs and issues; advancing care for women and girls with bleeding disorders

 Bills named in this filing 6
  • H.R. 1
    One Big Beautiful Bill Act
  • S. 864
    HELP Copays Act
  • H.R. 6423
    HELP Copays Act
  • H.R. 247
    Health Care Affordability Act of 2025
  • H.R. 5371
    Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions …
  • H.R. 1834
    Breaking the Gridlock Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem